Business Description
Pluri Inc. is an Israel-based biotechnology company founded in 2001 that uses placenta-derived cells to develop treatments for muscle injuries, blood disorders, and immune system conditions. The company also provides cell manufacturing services for outside partners and applies its cell-growth technology to food production, including lab-grown meat and cell-based coffee. Pluri works with Bar-Ilan University to explore new cancer treatments and operates across several sectors, from medicine to agriculture technology.
